# Johnson & Johnson (JNJ) — Q2-2023 Earnings Results

**Report date:** 2023-07-20 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2023

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Up 6.07%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.80 | N/A | +7.12% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's ability to navigate current market conditions. They noted that operational efficiencies are being prioritized.

**Key quotes:**

> Management highlighted strong performance in key segments, despite ongoing market challenges.

> They emphasized their commitment to innovation and maintaining market leadership.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Johnson & Johnson's strong EPS performance indicates solid profitability, which likely reassured investors. The stock rose by over 6% following the earnings report, reflecting positive market sentiment. However, the lack of revenue data and guidance leaves some uncertainty about future growth prospects.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2023_